FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
The agency is asking manufacturers, clinicians and the public to comment on risk assessment, premarket review and postmarket monitoring for GenAI devices.
8 Articles
8 Articles
FDA considering doctor-like assessment for AI-enabled devices
FDA wants feedback on how to regulate generative AI in medicine
“Generative AI-enabled medical devices are poised to reshape the health technology landscape, and the FDA has an important responsibility to provide thoughtful leadership for this new era,” says radiologist Rick Abramson, MD.
FDA Seeks Input on Generative AI Medical Device Regulation
The agency released a discussion paper to address the unique risks and potential of generative artificial intelligence in the healthcare ecosystem. The Food and Drug Administration (FDA) Digital Health Center of Excellence released a discussion paper regarding the regulation of generative artificial intelligence (AI)-enabled medical devices. The document is intended to engage stakeholders on the challenges and risks associated with the technolog…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium









